Acuvity, a leader in GenAI security and governance, today announced the release of its Open Source Secure MCP Server ...

NanoViricides highlighted several key reasons for prioritizing MPox as the first indication for NV-387's Phase II development, even with strong efficacy data in animal studies for other major viral ...